Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$233.45 - $247.73 $476,704 - $505,864
2,042 Added 46.99%
6,388 $1.58 Million
Q4 2023

Feb 06, 2024

BUY
$232.24 - $267.23 $69,439 - $79,901
299 Added 7.39%
4,346 $1.06 Million
Q3 2023

Nov 03, 2023

BUY
$254.9 - $283.59 $34,411 - $38,284
135 Added 3.45%
4,047 $1.05 Million
Q2 2023

Aug 04, 2023

BUY
$238.39 - $265.32 $16,687 - $18,572
70 Added 1.82%
3,912 $1.03 Million
Q1 2023

May 01, 2023

SELL
$229.71 - $259.35 $44,563 - $50,313
-194 Reduced 4.81%
3,842 $951,000
Q4 2022

Feb 07, 2023

SELL
$218.29 - $256.91 $78,802 - $92,744
-361 Reduced 8.21%
4,036 $1.03 Million
Q3 2022

Nov 03, 2022

BUY
$51.03 - $264.23 $102 - $528
2 Added 0.05%
4,397 $980,000
Q2 2022

Aug 02, 2022

BUY
$234.74 - $275.42 $234 - $275
1 Added 0.02%
4,395 $1.08 Million
Q1 2022

May 09, 2022

BUY
$243.64 - $270.48 $29,967 - $33,269
123 Added 2.88%
4,394 $1.17 Million
Q4 2021

Jan 26, 2022

SELL
$230.08 - $250.94 $38,423 - $41,906
-167 Reduced 3.76%
4,271 $1.07 Million
Q3 2021

Nov 05, 2021

SELL
$232.72 - $256.47 $61,903 - $68,221
-266 Reduced 5.65%
4,438 $1.09 Million
Q2 2021

Aug 13, 2021

SELL
$232.65 - $254.58 $19,309 - $21,130
-83 Reduced 1.73%
4,704 $1.14 Million
Q1 2021

May 10, 2021

BUY
$232.09 - $256.88 $124,400 - $137,687
536 Added 12.61%
4,787 $1.16 Million
Q4 2020

Feb 05, 2021

BUY
$221.92 - $245.94 $104,746 - $116,083
472 Added 12.49%
4,251 $1.06 Million
Q3 2020

Nov 09, 2020

BUY
$215.77 - $276.76 $221,164 - $283,679
1,025 Added 37.22%
3,779 $880,000
Q2 2020

Jul 31, 2020

SELL
$219.9 - $263.41 $87,740 - $105,100
-399 Reduced 12.65%
2,754 $658,000
Q1 2020

Apr 24, 2020

BUY
$195.69 - $279.01 $45,595 - $65,009
233 Added 7.98%
3,153 $725,000
Q4 2019

Feb 07, 2020

BUY
$236.45 - $266.82 $53,910 - $60,834
228 Added 8.47%
2,920 $795,000
Q3 2019

Nov 06, 2019

BUY
$230.58 - $256.08 $59,950 - $66,580
260 Added 10.69%
2,692 $681,000
Q2 2019

Aug 06, 2019

BUY
$217.4 - $246.08 $196,964 - $222,948
906 Added 59.37%
2,432 $612,000
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $44,506 - $53,604
216 Added 16.49%
1,526 $381,000
Q4 2018

Feb 08, 2019

BUY
$204.73 - $257.93 $6,141 - $7,737
30 Added 2.34%
1,310 $295,000
Q3 2018

Nov 06, 2018

BUY
$233.07 - $256.0 $20,743 - $22,784
89 Added 7.47%
1,280 $334,000
Q2 2018

Aug 08, 2018

SELL
$208.1 - $233.85 $18,312 - $20,578
-88 Reduced 6.88%
1,191 $285,000
Q1 2018

May 09, 2018

SELL
$205.46 - $240.27 $236,895 - $277,031
-1,153 Reduced 47.41%
1,279 $277,000
Q4 2017

Feb 13, 2018

BUY
$189.0 - $222.64 $459,648 - $541,460
2,432
2,432 $521,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.